You are here:

Accreditation scope for

TEST 271

Oslo universitetssykehus HF

Avdeling for farmakologi

Postboks 4950 Nydalen
0424 Oslo

Telephone: 22119464
E-mail: haueri@ous-hf.no.
Internet: http://www.oslo-universitetssykehus.no
The laboratory meets the requirements in

NS-EN ISO 15189:2022




Accreditation includes:
Hide all Show all
The administrative / geographical unit:
Klinisk farmakologi, seksjon Rikshospitalet
Sognsvannsv. 20
0027 OSLO


Permanent facility
M04 Clinical pharmacology
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Blod
Parameter
Ciklosporin
Reference standard
Internal method
Internal method identity
Dok.id. 94411
Comment
UHPLC-MS/MS
Object
Blood
Parameter
Everolimus
Reference standard
Internal method
Internal method identity
Dok.id. 94509
Comment
UHPLC-MS/MS
Object
Blood
Parameter
Sirolimus
Reference standard
Internal method
Internal method identity
Dok.id. 94515
Comment
UHPLC-MS/MS
Object
Blood
Parameter
Takrolimus
Reference standard
Internal method
Internal method identity
Dok.id. 73525
Comment
UHPLC-MS/MS
Object
Plasma
Parameter
Mycophenolate
Reference standard
Internal method
Internal method identity
Dok-Id 132280
Comment
Liquid chromatography with UV detection
Object
Plasma
Parameter
Imatinib
Reference standard
Internal method
Internal method identity
Dok-Id 145751
Comment
UHPLC-MS/MS
Object
Plasma
Parameter
Desmetylimatinib
Reference standard
Internal method
Internal method identity
Dok-Id 45751
Comment
UHPLC-MS/MS
Object
Plasma
Parameter
Busulfan
Reference standard
Internal method
Internal method identity
Dok.id. 127530
Comment
UHPLC-MS/MS
M31 Flexible accreditation
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Body fluids
Parameter
Pharmacological analytes
Reference standard
Internal method
Internal method identity
Measurement principle/analysis platforms which are accredited under clinical pharmacology (M04) Procedure for FA: Doc.id: 124450, 148567
Comment
An updated list of methods included in the flexible scope of accreditation, is available with the organization.
The administrative / geographical unit:
Klinisk farmakologi, Seksjon Spesialsykehuset for Epilepsi
G.F. Henriksens vei 29,
1337 Sandvika


Permanent facility
M04 Clinical pharmacology
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Serum
Parameter
Brivaracetam
Reference standard
Internal method
Internal method identity
Doc.Id:140499 BRI
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Eslikarbazepin - Likarbazepin
Reference standard
Internal method
Internal method identity
Doc.Id:140499 ESL
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Zonisamid
Reference standard
Internal method
Internal method identity
Doc.Id:140499 ZNS
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Valproat
Reference standard
Internal method
Internal method identity
Doc.Id:140499 VAL
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Felbamat
Reference standard
Internal method
Internal method identity
Doc.Id:140499 FELB
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Fenobarbital
Reference standard
Internal method
Internal method identity
Doc.Id:140499 FENOB
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Fenytoin
Reference standard
Internal method
Internal method identity
Doc.Id:140499 FENYT
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Gabapentin
Reference standard
Internal method
Internal method identity
Doc.Id:140499 GABA
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Karbamazepin
Reference standard
Internal method
Internal method identity
Doc.Id:140499 KARBZ
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Karbamazepinepoksid
Reference standard
Internal method
Internal method identity
Doc.Id:140499 KAREPO
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Lakosamid
Reference standard
Internal method
Internal method identity
Doc.Id:140499 LCM
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Lamotrigin
Reference standard
Internal method
Internal method identity
Doc.Id:140499 LAM
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Levetiracetam
Reference standard
Internal method
Internal method identity
Doc.Id:140499 LEVE
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Okskarbazepin - likarbazepin
Reference standard
Internal method
Internal method identity
Doc.Id:140499 OX
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Perampanel
Reference standard
Internal method
Internal method identity
Doc.Id:140499 PERA
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Pregabalin
Reference standard
Internal method
Internal method identity
Doc.Id:140499 PGB
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Rufinamid
Reference standard
Internal method
Internal method identity
Doc.Id:140499 RUF
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Stiripentol
Reference standard
Internal method
Internal method identity
Doc.Id:140499 ESM
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Sultiam
Reference standard
Internal method
Internal method identity
Doc.Id:140499 SULT
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Tiagabin
Reference standard
Internal method
Internal method identity
Doc.Id:140499 TIA
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Topiramat
Reference standard
Internal method
Internal method identity
Doc.Id:140499 TOP
Comment
UHPLC-MS/MS
Object
Serum
Parameter
Etosuksimid
Reference standard
Internal method
Internal method identity
Doc.Id:140499 ESM
Comment
UHPLC-MS/MS
M31 Flexible accreditation
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Body fluids
Parameter
Pharmacological analytes
Reference standard
Internal method
Internal method identity
Measurement principle/analysis platforms which are accredited under clinical pharmacology (M04) Procedure for FA: Doc.id:
Comment
An updated list of methods included in the flexible scope of accreditation, is available with the organization.
The administrative / geographical unit:
Klinisk farmakologi, seksjon Ullevål
Kirkeveien 166
0450 Oslo


Permanent facility
M04 Clinical pharmacology
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Urine
Parameter
Buprenorphine (non-specified)
Reference standard
Internal method
Internal method identity
49489 - UBUP
Comment
CEDIA AU680
Object
Urine
Parameter
Amphetamines (non-specified)
Reference standard
Internal method
Internal method identity
48891 - UAMF
Comment
EMIT AU680
Object
Urine
Parameter
Barbiturates (non-specified)
Reference standard
Internal method
Internal method identity
48969 - UBAR
Comment
CEDIA AU680
Object
Urine
Parameter
Cocaine (non-specified)
Reference standard
Internal method
Internal method identity
49529 - UKOK
Comment
CEDIA AU680
Object
Urine
Parameter
Methadone (non-specified)
Reference standard
Internal method
Internal method identity
49535 - UMDO
Comment
CEDIA AU680
Object
Urine
Parameter
EDDP (non-specified)
Reference standard
Internal method
Internal method identity
49537 - UEDP
Comment
CEDIA AU680
Object
Urine
Parameter
Cannabis (non-specified)
Reference standard
Internal method
Internal method identity
49482 - UCAN
Comment
CEDIA AU680
Object
Urine
Parameter
Ecstasy (MDMA) (non-specified)
Reference standard
Internal method
Internal method identity
49465 - UECS
Comment
DRI AU680
Object
Blood
Parameter
Phosphatidylethanol (PEth) 16:0/18:1
Reference standard
Internal method
Internal method identity
129189 - BPETH
Comment
LC-MS/MS
Object
Serum
Parameter
P-Amitriptylin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Nortriptylin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Citalopram
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Escitalopram
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Doksepin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Desmetyldoksepin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Duloksetin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Fluoksetin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Norfluoksetin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Fluvoksamin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Hydroksybupropion
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Klomipramin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-N-Desmetylklomipramin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Mirtazapin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Paroksetin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Sertralin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Trimipramin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Venlafaksin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-O-Desmetylvenlafaksin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Vortioksetin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Amisulprid
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Aripiprazol
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Dehydroaripiprazol
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Brekspiprazol
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Flupentiksol
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Haloperidol
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Klorprotiksen
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Klozapin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-N-desmetylklozapin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Kvetiapin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Lamotrigin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Levomepromazin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Desmetyldoksepin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Lurasidon
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Olanzapin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Perfenazin
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Risperidon
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Paliperidon (hydroksyrisperidon)
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Ziprasidon
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Serum
Parameter
P-Zuklopentiksol
Reference standard
Internal method
Internal method identity
DokID 141353
Comment
LCMS/MS
Object
Urine
Parameter
Opiats (non-specified)
Reference standard
Internal method
Internal method identity
140716 - UOPI
Comment
DRI AU680
Object
Urine
Parameter
Opiats (non-specified)
Reference standard
Internal method
Internal method identity
140716 - UOPI
Comment
DRI AU680
Object
Urine
Parameter
THC-syre (tetrahydrocannabinol acid))
Reference standard
Internal method
Internal method identity
43067 - UCAK
Comment
LC-MS/MS
Object
Urin
Parameter
pH
Reference standard
Internal method
Internal method identity
49600 - NPH
Comment
DRI AU680
Object
Urin
Parameter
Kreatinin
Reference standard
Internal method
Internal method identity
49469 - NKRE
Comment
DRI AU680
Object
Urine
Parameter
Benzodiazepines (non-specified)
Reference standard
Internal method
Internal method identity
49480 - UBEN
Comment
CEDIA AU680
M31 Flexible accreditation
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Body fluids
Parameter
Pharmacological analytes
Reference standard
Internal method
Internal method identity
Measurement principle/analysis platforms which are accredited under clinical pharmacology (M04) Procedure for FA: Doc.id:
Comment
An updated list of methods included in the flexible scope of accreditation, is available with the organization.